「イドルシア」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 同義語オン
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 0
- 期間を指定 17
- 日付指定なし 17
- 種類
- 写真 17
- グラフィックス 0
- 映像 0
- 向き
- 縦 2
- 横 15
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 16
- モノクロ 1
- 同義語辞書
- 古い順
- 1
- 古い順
-A SKETCH OF LIFE IN RUSSIA: TEACHING COSSACKS TO RIDE, 1880.A SKETCH OF LIFE IN RUSSIA: TEACHING COSSACKS TO RIDE, 1880.、クレジット：Ａｌｂｕｍ／ｑｕｉｎｔｌｏｘ／共同通信イメージズ ※エディトリアル使用のみ。表紙、広告、プロモーション、商業目的での利用はお問合せください。クレジットは必ず表記してください。
商品コード: 2021091412257
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: The journalist Emilio de Benito; the executive vice-president of Idorsia, Martine Clozel; the head of the Neurology Service of the La Mancha Centro Hospital Complex, Ana MarÃÂa González Manero; the professor and researcher Ramón y Cajal in Neurodegenerative Diseases, CIBERNED, IBIMA, and University of Malaga, Inés Moreno; the researcher and coordinator of the Occupational Risk Prevention Service at the Hospital de Castellón, Carmen Bellido Cambrón; and the president of the Spanish Federation of Sleep Medicine Societies, Carlos Javier Egea Santaolalla; pose after the informative meeting organized by Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: Scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its h...
商品コード: 2022092506937
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: The researcher and coordinator of the Occupational Risk Prevention Service at Hospital de Castellón, Carmen Bellido Cambrón, speaks during an informative meeting of Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its portfolio, indicated for the treatment of chronic insomnia in adults. According to the Spanish Society of Neurology, between 20 and 48% of the Spanish adult population suffers from difficulty in initiating or maintaining sleep...22 SEPTEMBER 2022;MEDICINE;NEUROLOGY;SLEEP;INSOMNIA;DRUG;PHARMACEUTICAL..Marta Fernández Jara / Europa Press..09/22/2022 (C...
商品コード: 2022092505787
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: (L-R) The president of the Spanish Federation of Sleep Medicine Societies, Carlos Javier Egea Santaolalla; the researcher and coordinator of the Occupational Risk Prevention Service at Castellón Hospital, Carmen Bellido Cambrón; the professor and researcher Ramón y Cajal in Neurodegenerative Diseases, CIBERNED, IBIMA, and University of Malaga, Inés Moreno; and the head of the Neurology Service of the La Mancha Centro Hospital Complex, Ana MarÃÂa González Manero; during an informative meeting organized by Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: Scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its po...
商品コード: 2022092506248
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: The researcher and coordinator of the Occupational Risk Prevention Service at Hospital de Castellón, Carmen Bellido Cambrón, speaks during an informative meeting of Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its portfolio, indicated for the treatment of chronic insomnia in adults. According to the Spanish Society of Neurology, between 20 and 48% of the Spanish adult population suffers from difficulty in initiating or maintaining sleep...22 SEPTEMBER 2022;MEDICINE;NEUROLOGY;SLEEP;INSOMNIA;DRUG;PHARMACEUTICAL..Marta Fernández Jara / Europa Press..09/22/2022 (C...
商品コード: 2022092506182
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: (L-R) The president of the Spanish Federation of Sleep Medicine Societies, Carlos Javier Egea Santaolalla; the researcher and coordinator of the Occupational Risk Prevention Service at Castellón Hospital, Carmen Bellido Cambrón; and the professor and Ramón y Cajal researcher in Neurodegenerative Diseases, CIBERNED, IBIMA, and University of Málaga, Inés Moreno; during an informative meeting of Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: Scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its portfolio, indicated for the treatment of chronic insomnia in adults. According to the Spanish Society of Neurology, ...
商品コード: 2022092506141
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: Journalist and consultant Emilio de Benito closes the informative meeting of Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its portfolio, indicated for the treatment of chronic insomnia in adults. According to the Spanish Society of Neurology, between 20 and 48% of the Spanish adult population suffers from difficulty in initiating or maintaining sleep...22 SEPTEMBER 2022;MEDICINE;NEUROLOGY;SLEEP;INSOMNIA;DRUG;PHARMACEUTICAL..Marta Fernández Jara / Europa Press..09/22/2022 (Credit Image: © Marta FernáNdez Jara/Contacto via ZUMA Press)、クレジット：©Ｍａｒｔａ ＦｅｒｎáＮｄｅｚ Ｊａ...
商品コード: 2022092506917
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: Idorsia‘s executive vice president, Martine Clozel; speaks at the Idorsia and Europa Press briefing entitled ‘Sleep, a pillar of social well-being: scientific talent in the field of sleep‘, at the Meeting Place Hotel, September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its portfolio, indicated for the treatment of chronic insomnia in adults. According to the Spanish Society of Neurology, between 20 and 48% of the Spanish adult population suffers from difficulty in initiating or maintaining sleep...22 SEPTEMBER 2022;MEDICINE;NEUROLOGY;SLEEP;INSOMNIA;DRUG;PHARMACEUTICAL..Marta Fernández Jara / Europa Press..09/22/2022 (Credit Image: © Marta FernáNdez Jara/Contacto via ZUMA Press)、クレジット：©Ｍａｒｔａ ＦｅｒｎáＮｄｅｚ Ｊａｒａ／Ｃｏｎｔａｃｔ...
商品コード: 2022092506909
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: The president of the Spanish Federation of Sleep Medicine Societies, Carlos Javier Egea Santaolalla, speaks during an informative meeting of Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its portfolio, indicated for the treatment of chronic insomnia in adults. According to the Spanish Society of Neurology, between 20 and 48% of the Spanish adult population suffers from difficulty in initiating or maintaining sleep...SEPTEMBER 22;2022..Marta Fernández Jara / Europa Press..09/22/2022 (Credit Image: © Marta FernáNdez Jara/Contacto via ZUMA Press)、クレジット：©Ｍａｒｔａ Ｆｅｒｎ...
商品コード: 2022092505875
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: The president of the Spanish Federation of Sleep Medicine Societies, Carlos Javier Egea Santaolalla, speaks during an informative meeting of Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its portfolio, indicated for the treatment of chronic insomnia in adults. According to the Spanish Society of Neurology, between 20 and 48% of the Spanish adult population suffers from difficulty in initiating or maintaining sleep...SEPTEMBER 22;2022..Marta Fernández Jara / Europa Press..09/22/2022 (Credit Image: © Marta FernáNdez Jara/Contacto via ZUMA Press)、クレジット：©Ｍａｒｔａ Ｆｅｒｎ...
商品コード: 2022092506095
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: (L-R) The president of the Spanish Federation of Sleep Medicine Societies, Carlos Javier Egea Santaolalla; the researcher and coordinator of the Occupational Risk Prevention Service at Castellón Hospital, Carmen Bellido Cambrón; the professor and researcher Ramón y Cajal in Neurodegenerative Diseases, CIBERNED, IBIMA, and University of Malaga, Inés Moreno; and the head of the Neurology Service of the La Mancha Centro Hospital Complex, Ana MarÃÂa González Manero; during an informative meeting organized by Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: Scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its po...
商品コード: 2022092506109
2022年09月22日Europa Press and Idorsia briefing on sleep as a pillar of social welfareSeptember 22, 2022, Madrid, Spain: Journalist and consultant Emilio de Benito closes the informative meeting of Idorsia and Europa Press, under the title ‘Sleep, a pillar of social welfare: scientific talent in the field of sleep‘, at the Meeting Place Hotel, on September 22, 2022, in Madrid (Spain). The Swiss-based biopharmaceutical company Idorsia specializes in the development and commercialization of small molecule treatments. Last May, Idorsia reached a milestone in its history when the European Commission granted marketing authorization for the first drug in its portfolio, indicated for the treatment of chronic insomnia in adults. According to the Spanish Society of Neurology, between 20 and 48% of the Spanish adult population suffers from difficulty in initiating or maintaining sleep...22 SEPTEMBER 2022;MEDICINE;NEUROLOGY;SLEEP;INSOMNIA;DRUG;PHARMACEUTICAL..Marta Fernández Jara / Europa Press..09/22/2022 (Credit Image: © Marta FernáNdez Jara/Contacto via ZUMA Press)、クレジット：©Ｍａｒｔａ ＦｅｒｎáＮｄｅｚ Ｊａ...
商品コード: 2022092506632
2023年06月24日Cagliari, 6th edition of the Filming Italy Sardegna Festival. Red Carpet third eveningCagliari, Italy: Cagliari, 6th edition of the Filming Italy Sardegna Festival. Third Evening Red Carpet Pictured: Dennis Quaid, Lucia Borgonzoni (Credit Image: © Manuele Mangiarotti/IPA via ZUMA Press)、クレジット：©Ｍａｎｕｅｌｅ Ｍａｎｇｉａｒｏｔｔｉ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Europe Rights OUT
商品コード: 2023062512183
2023年06月24日6th edition of the Filming Italy Sardegna FestivalDennis Quaid, Lucia Borgonzoni at the 6th edition of the Filming Italy Sardegna Festival, in Cagliari, Sardinia, on June 25, 2023. Photo by Manuele Mangiarotti /IPA/ABACAPRESS.COM、クレジット：Ｍａｎｇｉａｒｏｔｔｉ Ｍａｎｕｅｌｅ／ＩＰＡ／ＡＢＡＣＡ／共同通信イメージズ ※Italy Out
商品コード: 2023062602209
2023年06月26日Pula : Filming Italy Sardinia Festival . Fourth evening.Chaff, Italy: Pula : Filming Italy Sardinia Festival . Fourth evening. In the photo : Christopher Walken, Dennis Quaid, Lucia Borgonzoni, Emile Hirsch and Alessandro Nivola (Credit Image: © Maurizio D‘Avanzo/IPA via ZUMA Press)、クレジット：©Ｍａｕｒｉｚｉｏ Ｄ’Ａｖａｎｚｏ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Europe Rights OUT
商品コード: 2023062608106
2023年06月26日Pula : Filming Italy Sardinia Festival . Fourth evening.Chaff, Italy: Pula : Filming Italy Sardinia Festival . Fourth evening. In the photo : Tiziana Rocca ,Chistopher Walken,Dennis Quaid, Lucia Borgonzoni ,Emile Hirsch and Alessandro Nivola (Credit Image: © Maurizio D‘Avanzo/IPA via ZUMA Press)、クレジット：©Ｍａｕｒｉｚｉｏ Ｄ’Ａｖａｎｚｏ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Europe Rights OUT
商品コード: 2023062608296
2023年06月26日Pula : Filming Italy Sardinia Festival . Fourth evening.Chaff, Italy: Pula : Filming Italy Sardinia Festival . Fourth evening. In the photo : Christopher Walken, Dennis Quaid, Lucia Borgonzoni, Emile Hirsch and Alessandro Nivola (Credit Image: © Maurizio D‘Avanzo/IPA via ZUMA Press)、クレジット：©Ｍａｕｒｉｚｉｏ Ｄ’Ａｖａｎｚｏ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Europe Rights OUT
商品コード: 2023062608233
- 1
